Happy #OMFScienceWednesday! Just before leaving for the holidays, the T cell team met to plan out one of the projects we are funding at the ME/CFS Collaborative Research Center at Stanford. The team will follow up on Dr. Mark Davis’ observations of T cell activity in ME/CFS, to study a new cohort of patients and figure out what this T cell activity means for the understanding and treatment of the disease.
Some of the best technologies out there for sequencing the RNA and DNA of single T cells have been developed by this team! This was achieved through a collaboration between Drs. Mark Davis (Professor of Immunology & Microbiology) and Lars Steinmetz (Professor of Genetics), who will now apply these technologies to achieve new understanding of the role of T cells in ME/CFS. The team discussed which experiments they will perform in 2018 with the new funding from OMF, and developed plans to analyze and interpret the data. They are all excited to get started on this important project!
To keep up with the latest #OMFScienceWednesday posts, follow us on Facebook.
Donate your appreciated stock directly to OMF and you can receive an immediate income-tax deduction for the fair market value of the securities on the date of transfer (even if you originally paid much less for them).